Mode
Text Size
Log in / Sign up
N/A N=30 Randomized Single-blind Prevention

The Effect of Motor Imagery on Preventing Volleyball Players During Jumping and Landing

Motor Imagery

Enrolled (actual)
30
Serious AEs
Results posted
Apr 2026
Primary outcome: Primary: Kinematic Analysis: Change in Hip Flexion During Initial Contact. Baseline and 12 Weeks — -1.33; 5.1; 1.53 degrees

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
motor imagery (Other)
Age
Pediatric, Adult · 15+ yrs
Sex
All
Sponsor
Aydan Niziplioğlu
Primary completion
Oct 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Kinematic Analysis: Change in Hip Flexion During Initial Contact. Baseline and 12 Weeks
-1.33; 5.1; 1.53
PRIMARY
Kinematic Analysis: Change in Knee Flexion During Initial Contact.Baseline and 12 Weeks
-3.89; 1.44; -0.01
PRIMARY
Kinematic Analysis: Change in Right Knee Varus Degree During Initial Contact. Baseline and 12 Weeks
-2.97; -3.76; -0.15
PRIMARY
Kinematic Analysis: Change in Left Knee Varus Degree During Initial Contact. Baseline and 12 Weeks
-5.46; -5.1; -0.39
PRIMARY
Kinematic Analysis: Change in Ankle Flexion During Initial Contact. Baseline and 12 Weeks
-6.08; -0.19; 4.34
PRIMARY
Kinematic Analysis: Change in Hip Flexion During Full Contact.Baseline and 12 Weeks
-17.5; -12.0; -1.07
PRIMARY
Kinematic Analysis: Change in Knee Flexion During Full Contact. Beselina and 12 Weeks
-20.9; -14.7; -0.98
PRIMARY
Kinematic Analysis: Change in Right Knee Varus Degree During Full Contact: Baseline and 12. Weeks.
-9.74; -8.52; -1.21
PRIMARY
Kinematic Analysis: Change in Left Knee Varus Degree During Full Contact. Baseline and 12. Weeks
-7.44; -4.96; -0.31
PRIMARY
Kinematic Analysis: Change in Ankle Flexion During Full Contact. Baseline and 12. Weeks.
-6.03; -5.07; -1.49
SECONDARY
Change in Cognitive Functions - Neurocognition Index. Baseline and 12. Weeks
7.13; -1.29; -0.33
SECONDARY
Change in Cognitive Functions - Composite Memory. Beseline and 12. Weeks
8.33; 8.67; -8.83
SECONDARY
Change in Cognitive Functions - Verbal Memory. Baseline and 12. Weeks
13.7; 9.78; 5.17
SECONDARY
Change in Cognitive Functions - Visual Memory. Baseline and 12. Weeks
1.33; -2.33; -6.33
SECONDARY
Change in Cognitive Functions - Psychomotor Speed. Baseline and 12. Weeks
7.67; -6.8; 0.5
SECONDARY
Change in Cognitive Functions - Reaction Time. Baseline and 12. Weeks
11.6; 3.44; -1.67
SECONDARY
Change in Cognitive Functions - Complex Attention. Baseline and 12. Weeks
-3.5; 1.13; -14
SECONDARY
Change in Cognitive Functions - Cognitive Flexibility. Baseline and 12. Weeks.
7.67; 4.11; 10
SECONDARY
Change in Cognitive Functions - Processing Speed. Baseline and 12. Weeks
10.7; -6.3; 13.5
SECONDARY
Change in Cognitive Functions - Executive Function. Baseline and 12. Weeks
8.56; 0.2; 17.3
SECONDARY
Change in Cognitive Functions - Social Acuity. Baseline and 12. Weeks
-1; 6.1; 2.67
SECONDARY
Change in Cognitive Functions - Reasoning. Baseline and 12. Weeks
5.22; 4.67; 3.14
SECONDARY
Change in Cognitive Functions - Working Memory. Baseline and 12. Weeks
-0.86; 2.56; 14.7
SECONDARY
Change in Cognitive Functions - Sustained Attention. Baseline and 12. Weeks
1.86; 1.78; 11.3
SECONDARY
Change in Cognitive Functions - Simple Attention. Baseline and 12. Weeks
-24.9; 0.22; 10.8
SECONDARY
Change in Cognitive Functions - Motor Speed. Baseline and 12. Weeks
2.22; -7.3; 2.38

Summary

Although the effectiveness of motor imagery in improving performance in sports is known, there is no research on its preventive role against injuries. the primary aim of this study is to investigate the effect of motor imagery on improving risk factors related to jumps and falls in volleyball players. The secondary aim of this study is to investigate the effect of motor imagery on cortical functions.

Eligibility Criteria

Inclusion Criteria

  • To be between the ages of 15 and 25,
  • Not have an injury that affects the player's training program
  • Play regularly for a professional team.

Exclusion Criteria

  • had lower extremity injury in the last two months
  • who had been diagnosed with attention deficit hyperactivity disorder
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07009080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search